TD Asset Management

TD Asset Management Portfolio holdings

AUM $124B
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+30.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$124B
AUM Growth
+$1.17B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,313
New
Increased
Reduced
Closed

Top Buys

1 +$281M
2 +$265M
3 +$230M
4
AAPL icon
Apple
AAPL
+$211M
5
COR icon
Cencora
COR
+$194M

Top Sells

1 +$626M
2 +$409M
3 +$224M
4
MSI icon
Motorola Solutions
MSI
+$206M
5
ORCL icon
Oracle
ORCL
+$201M

Sector Composition

1 Financials 23.38%
2 Technology 22.53%
3 Industrials 9.15%
4 Healthcare 8.46%
5 Consumer Discretionary 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGSWW
1226
GeneDx Holdings Warrant
WGSWW
$240K
$1.65K ﹤0.01%
34,884
ACAD icon
1227
Acadia Pharmaceuticals
ACAD
$3.85B
-65,000
ACI icon
1228
Albertsons Companies
ACI
$8.85B
-44,400
AKRO
1229
DELISTED
Akero Therapeutics
AKRO
-188,844
ALEC icon
1230
Alector
ALEC
$242M
-273,738
AMCR icon
1231
Amcor
AMCR
$19.5B
-253,868
AMLX icon
1232
Amylyx Pharmaceuticals
AMLX
$1.57B
-40,966
AMPL icon
1233
Amplitude
AMPL
$1.04B
-173,606
ATAI icon
1234
AtaiBeckley Inc
ATAI
$1.41B
-68,576
AXS icon
1235
AXIS Capital
AXS
$7.81B
-135,400
BFAM icon
1236
Bright Horizons
BFAM
$4.26B
-146,920
BHP icon
1237
BHP
BHP
$185B
-13,000
BMI icon
1238
Badger Meter
BMI
$4.36B
-6,718
BMRN icon
1239
BioMarin Pharmaceuticals
BMRN
$11.7B
-16,605
BPOP icon
1240
Popular Inc
BPOP
$8.44B
-13,880
CADE
1241
DELISTED
Cadence Bank
CADE
-106,720
CAVA icon
1242
CAVA Group
CAVA
$9.52B
-3,800
CCK icon
1243
Crown Holdings
CCK
$11.9B
-10,228
CFLT icon
1244
Confluent
CFLT
$11B
-58,792
CWAN icon
1245
Clearwater Analytics
CWAN
$6.88B
-100,426
ELVN icon
1246
Enliven Therapeutics
ELVN
$1.76B
-27,518
EMB icon
1247
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$16.2B
-55,500
EMLC icon
1248
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.97B
-201,000
EMN icon
1249
Eastman Chemical
EMN
$7.94B
-20,201
EXAS icon
1250
Exact Sciences
EXAS
$19.8B
-132,304